世界の女性不妊症診断・治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Female Infertility Diagnosis and Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2333 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、女性不妊症診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療薬・医薬品、手術、子宮内授精（IUI）、生殖補助医療（ART））、用途別市場規模（病院・クリニック、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・女性不妊症診断・治療の市場動向 ・企業の競争状況、市場シェア ・女性不妊症診断・治療の種類別市場規模（治療薬・医薬品、手術、子宮内授精（IUI）、生殖補助医療（ART）） ・女性不妊症診断・治療の用途別市場規模（病院・クリニック、診断センター） ・女性不妊症診断・治療の北米市場規模2016-2027（アメリカ、カナダ） ・女性不妊症診断・治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・女性不妊症診断・治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・女性不妊症診断・治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・女性不妊症診断・治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer、Bristol-Myers Squibb、Church & Dwight、Cook Medical、CooperSurgical、Eli Lilly、EMD Serono、Endo、Ferring Pharmaceuticals、Genea、GSK、Halotech DNA、Irvine Scientific、Janssen、Merck、Novartis、Origio、Pfizer、OvaScience） ・結論

Market Analysis and Insights: Global Female Infertility Diagnosis and Treatment Market
The global Female Infertility Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Female Infertility Diagnosis and Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Female Infertility Diagnosis and Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Female Infertility Diagnosis and Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Female Infertility Diagnosis and Treatment market.

Global Female Infertility Diagnosis and Treatment Scope and Market Size
Female Infertility Diagnosis and Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Female Infertility Diagnosis and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drugs and medicine
Surgical
Intrauterine insemination (IUI)
Assisted reproductive technology (ART)

Segment by Application
Hospitals and Clinics
Diagnostic Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
Bristol-Myers Squibb
Church & Dwight
Cook Medical
CooperSurgical
Eli Lilly
EMD Serono
Endo
Ferring Pharmaceuticals
Cook Medical
CooperSurgical
Halotech DNA
Irvine Scientific
Janssen
Merck
Novartis
Origio

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Female Infertility Diagnosis and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs and medicine
1.2.3 Surgical
1.2.4 Intrauterine insemination (IUI)
1.2.5 Assisted reproductive technology (ART)
1.3 Market by Application
1.3.1 Global Female Infertility Diagnosis and Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Female Infertility Diagnosis and Treatment Market Perspective (2016-2027)
2.2 Female Infertility Diagnosis and Treatment Growth Trends by Regions
2.2.1 Female Infertility Diagnosis and Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Female Infertility Diagnosis and Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Female Infertility Diagnosis and Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Female Infertility Diagnosis and Treatment Industry Dynamic
2.3.1 Female Infertility Diagnosis and Treatment Market Trends
2.3.2 Female Infertility Diagnosis and Treatment Market Drivers
2.3.3 Female Infertility Diagnosis and Treatment Market Challenges
2.3.4 Female Infertility Diagnosis and Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Female Infertility Diagnosis and Treatment Players by Revenue
3.1.1 Global Top Female Infertility Diagnosis and Treatment Players by Revenue (2016-2021)
3.1.2 Global Female Infertility Diagnosis and Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Female Infertility Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Female Infertility Diagnosis and Treatment Revenue
3.4 Global Female Infertility Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Female Infertility Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Female Infertility Diagnosis and Treatment Revenue in 2020
3.5 Female Infertility Diagnosis and Treatment Key Players Head office and Area Served
3.6 Key Players Female Infertility Diagnosis and Treatment Product Solution and Service
3.7 Date of Enter into Female Infertility Diagnosis and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Female Infertility Diagnosis and Treatment Breakdown Data by Type
4.1 Global Female Infertility Diagnosis and Treatment Historic Market Size by Type (2016-2021)
4.2 Global Female Infertility Diagnosis and Treatment Forecasted Market Size by Type (2022-2027)

5 Female Infertility Diagnosis and Treatment Breakdown Data by Application
5.1 Global Female Infertility Diagnosis and Treatment Historic Market Size by Application (2016-2021)
5.2 Global Female Infertility Diagnosis and Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Female Infertility Diagnosis and Treatment Market Size (2016-2027)
6.2 North America Female Infertility Diagnosis and Treatment Market Size by Type
6.2.1 North America Female Infertility Diagnosis and Treatment Market Size by Type (2016-2021)
6.2.2 North America Female Infertility Diagnosis and Treatment Market Size by Type (2022-2027)
6.2.3 North America Female Infertility Diagnosis and Treatment Market Size by Type (2016-2027)
6.3 North America Female Infertility Diagnosis and Treatment Market Size by Application
6.3.1 North America Female Infertility Diagnosis and Treatment Market Size by Application (2016-2021)
6.3.2 North America Female Infertility Diagnosis and Treatment Market Size by Application (2022-2027)
6.3.3 North America Female Infertility Diagnosis and Treatment Market Size by Application (2016-2027)
6.4 North America Female Infertility Diagnosis and Treatment Market Size by Country
6.4.1 North America Female Infertility Diagnosis and Treatment Market Size by Country (2016-2021)
6.4.2 North America Female Infertility Diagnosis and Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Female Infertility Diagnosis and Treatment Market Size (2016-2027)
7.2 Europe Female Infertility Diagnosis and Treatment Market Size by Type
7.2.1 Europe Female Infertility Diagnosis and Treatment Market Size by Type (2016-2021)
7.2.2 Europe Female Infertility Diagnosis and Treatment Market Size by Type (2022-2027)
7.2.3 Europe Female Infertility Diagnosis and Treatment Market Size by Type (2016-2027)
7.3 Europe Female Infertility Diagnosis and Treatment Market Size by Application
7.3.1 Europe Female Infertility Diagnosis and Treatment Market Size by Application (2016-2021)
7.3.2 Europe Female Infertility Diagnosis and Treatment Market Size by Application (2022-2027)
7.3.3 Europe Female Infertility Diagnosis and Treatment Market Size by Application (2016-2027)
7.4 Europe Female Infertility Diagnosis and Treatment Market Size by Country
7.4.1 Europe Female Infertility Diagnosis and Treatment Market Size by Country (2016-2021)
7.4.2 Europe Female Infertility Diagnosis and Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Female Infertility Diagnosis and Treatment Market Size (2016-2027)
8.2 Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Type
8.2.1 Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Application
8.3.1 Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Region
8.4.1 Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Female Infertility Diagnosis and Treatment Market Size (2016-2027)
9.2 Latin America Female Infertility Diagnosis and Treatment Market Size by Type
9.2.1 Latin America Female Infertility Diagnosis and Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Female Infertility Diagnosis and Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Female Infertility Diagnosis and Treatment Market Size by Type (2016-2027)
9.3 Latin America Female Infertility Diagnosis and Treatment Market Size by Application
9.3.1 Latin America Female Infertility Diagnosis and Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Female Infertility Diagnosis and Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Female Infertility Diagnosis and Treatment Market Size by Application (2016-2027)
9.4 Latin America Female Infertility Diagnosis and Treatment Market Size by Country
9.4.1 Latin America Female Infertility Diagnosis and Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Female Infertility Diagnosis and Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Female Infertility Diagnosis and Treatment Market Size (2016-2027)
10.2 Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Type
10.2.1 Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Application
10.3.1 Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Country
10.4.1 Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Female Infertility Diagnosis and Treatment Introduction
11.1.4 Bayer Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Female Infertility Diagnosis and Treatment Introduction
11.2.4 Bristol-Myers Squibb Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Church & Dwight
11.3.1 Church & Dwight Company Details
11.3.2 Church & Dwight Business Overview
11.3.3 Church & Dwight Female Infertility Diagnosis and Treatment Introduction
11.3.4 Church & Dwight Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.3.5 Church & Dwight Recent Development
11.4 Cook Medical
11.4.1 Cook Medical Company Details
11.4.2 Cook Medical Business Overview
11.4.3 Cook Medical Female Infertility Diagnosis and Treatment Introduction
11.4.4 Cook Medical Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.4.5 Cook Medical Recent Development
11.5 CooperSurgical
11.5.1 CooperSurgical Company Details
11.5.2 CooperSurgical Business Overview
11.5.3 CooperSurgical Female Infertility Diagnosis and Treatment Introduction
11.5.4 CooperSurgical Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.5.5 CooperSurgical Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Female Infertility Diagnosis and Treatment Introduction
11.6.4 Eli Lilly Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 EMD Serono
11.7.1 EMD Serono Company Details
11.7.2 EMD Serono Business Overview
11.7.3 EMD Serono Female Infertility Diagnosis and Treatment Introduction
11.7.4 EMD Serono Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.7.5 EMD Serono Recent Development
11.8 Endo
11.8.1 Endo Company Details
11.8.2 Endo Business Overview
11.8.3 Endo Female Infertility Diagnosis and Treatment Introduction
11.8.4 Endo Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.8.5 Endo Recent Development
11.9 Ferring Pharmaceuticals
11.9.1 Ferring Pharmaceuticals Company Details
11.9.2 Ferring Pharmaceuticals Business Overview
11.9.3 Ferring Pharmaceuticals Female Infertility Diagnosis and Treatment Introduction
11.9.4 Ferring Pharmaceuticals Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.9.5 Ferring Pharmaceuticals Recent Development
11.10 Genea
11.10.1 Genea Company Details
11.10.2 Genea Business Overview
11.10.3 Genea Female Infertility Diagnosis and Treatment Introduction
11.10.4 Genea Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.10.5 Genea Recent Development
11.11 GSK
11.11.1 GSK Company Details
11.11.2 GSK Business Overview
11.11.3 GSK Female Infertility Diagnosis and Treatment Introduction
11.11.4 GSK Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.11.5 GSK Recent Development
11.12 Halotech DNA
11.12.1 Halotech DNA Company Details
11.12.2 Halotech DNA Business Overview
11.12.3 Halotech DNA Female Infertility Diagnosis and Treatment Introduction
11.12.4 Halotech DNA Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.12.5 Halotech DNA Recent Development
11.13 Irvine Scientific
11.13.1 Irvine Scientific Company Details
11.13.2 Irvine Scientific Business Overview
11.13.3 Irvine Scientific Female Infertility Diagnosis and Treatment Introduction
11.13.4 Irvine Scientific Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.13.5 Irvine Scientific Recent Development
11.14 Janssen
11.14.1 Janssen Company Details
11.14.2 Janssen Business Overview
11.14.3 Janssen Female Infertility Diagnosis and Treatment Introduction
11.14.4 Janssen Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.14.5 Janssen Recent Development
11.15 Merck
11.15.1 Merck Company Details
11.15.2 Merck Business Overview
11.15.3 Merck Female Infertility Diagnosis and Treatment Introduction
11.15.4 Merck Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.15.5 Merck Recent Development
11.16 Novartis
11.16.1 Novartis Company Details
11.16.2 Novartis Business Overview
11.16.3 Novartis Female Infertility Diagnosis and Treatment Introduction
11.16.4 Novartis Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.16.5 Novartis Recent Development
11.17 Origio
11.17.1 Origio Company Details
11.17.2 Origio Business Overview
11.17.3 Origio Female Infertility Diagnosis and Treatment Introduction
11.17.4 Origio Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.17.5 Origio Recent Development
11.18 Pfizer
11.18.1 Pfizer Company Details
11.18.2 Pfizer Business Overview
11.18.3 Pfizer Female Infertility Diagnosis and Treatment Introduction
11.18.4 Pfizer Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
11.18.5 Pfizer Recent Development
11.18 OvaScience
.1 OvaScience Company Details
.2 OvaScience Business Overview
.3 OvaScience Female Infertility Diagnosis and Treatment Introduction
.4 OvaScience Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021)
.5 OvaScience Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Female Infertility Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs and medicine
Table 3. Key Players of Surgical
Table 4. Key Players of Intrauterine insemination (IUI)
Table 5. Key Players of Assisted reproductive technology (ART)
Table 6. Global Female Infertility Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Female Infertility Diagnosis and Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Female Infertility Diagnosis and Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Female Infertility Diagnosis and Treatment Market Share by Regions (2016-2021)
Table 10. Global Female Infertility Diagnosis and Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Female Infertility Diagnosis and Treatment Market Share by Regions (2022-2027)
Table 12. Female Infertility Diagnosis and Treatment Market Trends
Table 13. Female Infertility Diagnosis and Treatment Market Drivers
Table 14. Female Infertility Diagnosis and Treatment Market Challenges
Table 15. Female Infertility Diagnosis and Treatment Market Restraints
Table 16. Global Female Infertility Diagnosis and Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Female Infertility Diagnosis and Treatment Market Share by Players (2016-2021)
Table 18. Global Top Female Infertility Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Infertility Diagnosis and Treatment as of 2020)
Table 19. Ranking of Global Top Female Infertility Diagnosis and Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Female Infertility Diagnosis and Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Female Infertility Diagnosis and Treatment Product Solution and Service
Table 23. Date of Enter into Female Infertility Diagnosis and Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Female Infertility Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Female Infertility Diagnosis and Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Female Infertility Diagnosis and Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Female Infertility Diagnosis and Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Female Infertility Diagnosis and Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Female Infertility Diagnosis and Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Female Infertility Diagnosis and Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Female Infertility Diagnosis and Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Female Infertility Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Female Infertility Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Female Infertility Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Female Infertility Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Female Infertility Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Female Infertility Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Female Infertility Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Female Infertility Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Female Infertility Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Female Infertility Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Female Infertility Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Female Infertility Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Female Infertility Diagnosis and Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Female Infertility Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Female Infertility Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Female Infertility Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Female Infertility Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Female Infertility Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Female Infertility Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Female Infertility Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bayer Company Details
Table 64. Bayer Business Overview
Table 65. Bayer Female Infertility Diagnosis and Treatment Product
Table 66. Bayer Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. Bristol-Myers Squibb Company Details
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Female Infertility Diagnosis and Treatment Product
Table 71. Bristol-Myers Squibb Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 72. Bristol-Myers Squibb Recent Development
Table 73. Church & Dwight Company Details
Table 74. Church & Dwight Business Overview
Table 75. Church & Dwight Female Infertility Diagnosis and Treatment Product
Table 76. Church & Dwight Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 77. Church & Dwight Recent Development
Table 78. Cook Medical Company Details
Table 79. Cook Medical Business Overview
Table 80. Cook Medical Female Infertility Diagnosis and Treatment Product
Table 81. Cook Medical Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 82. Cook Medical Recent Development
Table 83. CooperSurgical Company Details
Table 84. CooperSurgical Business Overview
Table 85. CooperSurgical Female Infertility Diagnosis and Treatment Product
Table 86. CooperSurgical Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 87. CooperSurgical Recent Development
Table 88. Eli Lilly Company Details
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Female Infertility Diagnosis and Treatment Product
Table 91. Eli Lilly Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 92. Eli Lilly Recent Development
Table 93. EMD Serono Company Details
Table 94. EMD Serono Business Overview
Table 95. EMD Serono Female Infertility Diagnosis and Treatment Product
Table 96. EMD Serono Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 97. EMD Serono Recent Development
Table 98. Endo Company Details
Table 99. Endo Business Overview
Table 100. Endo Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 101. Endo Recent Development
Table 102. Ferring Pharmaceuticals Company Details
Table 103. Ferring Pharmaceuticals Business Overview
Table 104. Ferring Pharmaceuticals Female Infertility Diagnosis and Treatment Product
Table 105. Ferring Pharmaceuticals Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 106. Ferring Pharmaceuticals Recent Development
Table 107. Genea Company Details
Table 108. Genea Business Overview
Table 109. Genea Female Infertility Diagnosis and Treatment Product
Table 110. Genea Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 111. Genea Recent Development
Table 112. GSK Company Details
Table 113. GSK Business Overview
Table 114. GSK Female Infertility Diagnosis and Treatment Product
Table 115. GSK Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 116. GSK Recent Development
Table 117. Halotech DNA Company Details
Table 118. Halotech DNA Business Overview
Table 119. Halotech DNA Female Infertility Diagnosis and Treatment Product
Table 120. Halotech DNA Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 121. Halotech DNA Recent Development
Table 122. Irvine Scientific Company Details
Table 123. Irvine Scientific Business Overview
Table 124. Irvine Scientific Female Infertility Diagnosis and Treatment Product
Table 125. Irvine Scientific Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 126. Irvine Scientific Recent Development
Table 127. Janssen Company Details
Table 128. Janssen Business Overview
Table 129. Janssen Female Infertility Diagnosis and Treatment Product
Table 130. Janssen Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 131. Janssen Recent Development
Table 132. Merck Company Details
Table 133. Merck Business Overview
Table 134. Merck Female Infertility Diagnosis and Treatment Product
Table 135. Merck Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 136. Merck Recent Development
Table 137. Novartis Company Details
Table 138. Novartis Business Overview
Table 139. Novartis Female Infertility Diagnosis and Treatment Product
Table 140. Novartis Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 141. Novartis Recent Development
Table 142. Origio Company Details
Table 143. Origio Business Overview
Table 144. Origio Female Infertility Diagnosis and Treatment Product
Table 145. Origio Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 146. Origio Recent Development
Table 147. Pfizer Company Details
Table 148. Pfizer Business Overview
Table 149. Pfizer Female Infertility Diagnosis and Treatment Product
Table 150. Pfizer Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 151. Pfizer Recent Development
Table 152. OvaScience Company Details
Table 153. OvaScience Business Overview
Table 154. OvaScience Female Infertility Diagnosis and Treatment Product
Table 155. OvaScience Revenue in Female Infertility Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 156. OvaScience Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Female Infertility Diagnosis and Treatment Market Share by Type: 2020 VS 2027
Figure 2. Drugs and medicine Features
Figure 3. Surgical Features
Figure 4. Intrauterine insemination (IUI) Features
Figure 5. Assisted reproductive technology (ART) Features
Figure 6. Global Female Infertility Diagnosis and Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Female Infertility Diagnosis and Treatment Report Years Considered
Figure 10. Global Female Infertility Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Female Infertility Diagnosis and Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Female Infertility Diagnosis and Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Female Infertility Diagnosis and Treatment Market Share by Regions (2022-2027)
Figure 14. Global Female Infertility Diagnosis and Treatment Market Share by Players in 2020
Figure 15. Global Top Female Infertility Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Infertility Diagnosis and Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Female Infertility Diagnosis and Treatment Revenue in 2020
Figure 17. Global Female Infertility Diagnosis and Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Female Infertility Diagnosis and Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Female Infertility Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 21. North America Female Infertility Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 22. North America Female Infertility Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 23. United States Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Female Infertility Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 27. Europe Female Infertility Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 28. Europe Female Infertility Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 29. Germany Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Female Infertility Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Female Infertility Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Female Infertility Diagnosis and Treatment Market Share by Region (2016-2027)
Figure 39. China Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Female Infertility Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Female Infertility Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Female Infertility Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Female Infertility Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Female Infertility Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Female Infertility Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Female Infertility Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bayer Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 60. Church & Dwight Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 61. Cook Medical Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 62. CooperSurgical Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 64. EMD Serono Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 65. Endo Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 66. Ferring Pharmaceuticals Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 67. Genea Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 68. GSK Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 69. Halotech DNA Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 70. Irvine Scientific Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 71. Janssen Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 72. Merck Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 73. Novartis Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 74. Origio Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 75. Pfizer Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 76. OvaScience Revenue Growth Rate in Female Infertility Diagnosis and Treatment Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

---